サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1293975

創傷生物製剤の世界市場：製品タイプ別、創傷タイプ別、エンドユーザー別 - 2023年～2030年の予測

Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
創傷生物製剤の世界市場：製品タイプ別、創傷タイプ別、エンドユーザー別 - 2023年～2030年の予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創傷生物製剤の市場規模は大きく成長し、2023年にはCAGR9.82%で49億8,096万米ドルとなり、2030年までに97億412万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の創傷生物製剤市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.創傷生物製剤の世界市場規模および予測は？

2.予測期間中、創傷生物製剤の世界市場を形成するCOVID-19の阻害要因と影響は？

3.創傷生物製剤の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.創傷生物製剤の世界市場における競争戦略は？

5.創傷生物製剤の世界市場における技術動向と規制の枠組みは？

6.創傷生物製剤の世界市場における主要ベンダーの市場シェアは？

7.創傷生物製剤の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 創傷治療に関する政府の取り組み
      • 火傷と交通事故の増加
      • 世界的に増加する高齢者人口
    • 抑制要因
      • 高額な創傷治療費
    • 機会
      • 革新的な創傷治療用生物製剤のイントロダクション
      • 外科手術における生体工学による代用皮膚の潜在的なニーズ
    • 課題
      • 訓練を受けた医師の不足と汚染に伴う合併症
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 創傷生物製剤市場：製品タイプ別

  • 生物学的皮膚代替品
    • 無細胞動物由来製品
    • 生合成製品
    • ヒトドナー組織由来製品
  • 外用剤

第7章 創傷生物製剤市場：創傷タイプ別

  • 火傷
  • 外科的創傷および外傷性創傷
  • 潰瘍
    • 糖尿病性足潰瘍
    • 褥瘡
    • 静脈性潰瘍

第8章 創傷生物製剤市場：エンドユーザー別

  • 外来手術センター
  • 熱傷センター
  • 病院
  • 創傷クリニック

第9章 南北アメリカの創傷生物製剤市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の創傷生物製剤市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの創傷生物製剤市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. WOUND BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOUND BIOLOGICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2022 VS 2030 (%)
  • FIGURE 6. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. WOUND BIOLOGICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. WOUND BIOLOGICS MARKET DYNAMICS
  • FIGURE 9. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 6. WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 15. WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 234. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 235. WOUND BIOLOGICS MARKET LICENSE & PRICING
目次
Product Code: MRR-0315DDADCE4C

The Global Wound Biologics Market is forecasted to grow significantly, with a projected USD 4,980.96 million in 2023 at a CAGR of 9.82% and expected to reach a staggering USD 9,704.12 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Wound Biologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Wound Biologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products. The Biologic Skin Substitutes commanded largest market share of 43.53% in 2022, followed by Topical Agents.

Based on Wound Type, market is studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers. The Surgical and Traumatic Wounds commanded largest market share of 42.71% in 2022, followed by Ulcers.

Based on End-User, market is studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics. The Hospitals commanded largest market share of 39.22% in 2022, followed by Ambulatory Surgery Centers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 42.03% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Wound Biologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Wound Biologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wound Biologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wound Biologics Market?

4. What is the competitive strategic window for opportunities in the Global Wound Biologics Market?

5. What are the technology trends and regulatory frameworks in the Global Wound Biologics Market?

6. What is the market share of the leading vendors in the Global Wound Biologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Wound Biologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Wound Biologics Market, by Product, 2022 vs 2030
  • 4.3. Wound Biologics Market, by Wound Type, 2022 vs 2030
  • 4.4. Wound Biologics Market, by End-User, 2022 vs 2030
  • 4.5. Wound Biologics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government Initiatives Regarding Wound Care Treatment
      • 5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
      • 5.1.1.3. Increasing Geriatric Population Globally
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Wound Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of Innovative Wound Care Biologics
      • 5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Wound Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Biologic Skin Substitutes
    • 6.2.1. Acellular Animal-derived Products
    • 6.2.2. Biosynthetic Products
    • 6.2.3. Human Donor Tissue-derived Products
  • 6.3. Topical Agents

7. Wound Biologics Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Burns
  • 7.3. Surgical and Traumatic Wounds
  • 7.4. Ulcers
    • 7.4.1. Diabetic Foot Ulcers
    • 7.4.2. Pressure Ulcers
    • 7.4.3. Venous Ulcers

8. Wound Biologics Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Burn Centers
  • 8.4. Hospitals
  • 8.5. Wound Clinics

9. Americas Wound Biologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wound Biologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wound Biologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. 3M Company

2. Anika Therapeutics, Inc

3. Avita Medical, Inc.

4. Bioventus Inc.

5. Blaine Labs Inc.

6. ConvaTec Group PLC

7. Cytori Therapeutics Inc.

8. Integra Lifesciences Holdings Corporation

9. Kerecis hf

10. Marine Polymer Technologies, Inc.

11. MediWound Ltd.

12. MIMEDX GROUP, INC.

13. Molnlycke Health Care AB

14. Nuo Therapeutics, Inc.

15. Organogenesis Inc.

16. Polymedics Innovations GmbH

17. Royal Biologics, Inc.

18. Skye Biologics Holdings, LLC

19. Smith & Nephew PLC

20. Stability Biologics

21. Stryker Corporation

22. Surgilogix, LLC

23. Tides Medical

24. Vericel Corporation

25. Viatris Inc.